Innovative Drug Synthesis
Latest Publications

TOTAL DOCUMENTS

19

(FIVE YEARS 0)

H-INDEX

1

(FIVE YEARS 0)

Published By John Wiley & Sons, Inc

9781118819951, 9781118820056

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Sofosbuvir (Sovaldi): The First-in-Class HCV NS5B Nucleotide Polymerase Inhibitor

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch4 ◽

2015 ◽

pp. 61-80 ◽

Author(s):

Raymond F. Schinazi ◽

Junxing Shi ◽

Tony Whitaker

Keyword(s):

Polymerase Inhibitor ◽

Download Full-text

Bedaquiline (Situro): A Diarylquinoline that Blocks Tuberculosis ATP Synthase for the Treatment of Multi-Drug Resistant Tuberculosis

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch5 ◽

2015 ◽

pp. 81-98

Author(s):

Elizabeth N. Cruz ◽

Amanda N. Moules ◽

Jie Jack Li

Keyword(s):

Atp Synthase ◽

Drug Resistant ◽

Drug Resistant Tuberculosis ◽

Resistant Tuberculosis ◽

Multi Drug Resistant Tuberculosis

Download Full-text

Ibrutinib (Imbruvica): The First-in-Class Btk Inhibitor for Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch8 ◽

2015 ◽

pp. 157-166

Author(s):

Hui Liu ◽

Zhengying Pan

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Lymphocytic Leukemia ◽

Waldenström’S Macroglobulinemia ◽

Mantle Cell ◽

Btk Inhibitor ◽

Waldenstrom's Macroglobulinemia ◽

Waldenstrom’S Macroglobulinemia ◽

Waldenström's Macroglobulinemia

Download Full-text

Daclatasvir (Daklinza): The First-in-Class HCV NS5A Replication Complex Inhibitor

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch3 ◽

2015 ◽

pp. 43-60

Author(s):

Makonen Belema ◽

Shawn K. Pack ◽

Nicholas A. Meanwell

Keyword(s):

Replication Complex

Download Full-text

Index

Innovative Drug Synthesis ◽

10.1002/9781118819951.index ◽

2015 ◽

pp. 331-341

Download Full-text

Ivacaftor (Kalydeco): A CFTR Potentiator for the Treatment of Cystic Fibrosis

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch16 ◽

2015 ◽

pp. 303-316 ◽

Author(s):

Cho K. Lai ◽

Theresa V. Song ◽

Jie Jack Li

Keyword(s):

Cystic Fibrosis

Download Full-text

Palbociclib (Ibrance): The First-in-Class CDK4/6 Inhibitor for Breast Cancer

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch9 ◽

2015 ◽

pp. 167-196

Author(s):

Peter L. Toogood ◽

Nathan D. Ide

Keyword(s):

Download Full-text

Front Matter

Innovative Drug Synthesis ◽

10.1002/9781118819951.fmatter ◽

2015 ◽

pp. i-xvi

Download Full-text

Enzalutamide (Xtandi): An Androgen Receptor Antagonist for Late-Stage Prostate Cancer

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch6 ◽

2015 ◽

pp. 99-118

Author(s):

Sha Lou ◽

Ji Zhang

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Receptor Antagonist ◽

Androgen Receptor Antagonist

Download Full-text

Febuxostat (Uloric): A Xanthine Oxidase Inhibitor for the Treatment of Gout

Innovative Drug Synthesis ◽

10.1002/9781118819951.ch17 ◽

2015 ◽

pp. 317-330

Author(s):

Ji Zhang ◽

Yingjun Zhang

Keyword(s):

Xanthine Oxidase ◽

Oxidase Inhibitor ◽

Xanthine Oxidase Inhibitor

Download Full-text